PL-3994 Aqueous Intravenous Solution Dose Ascention

Drug identity checked against registry records

Also recorded as PL-3994

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

TrialSponsorPhaseStatusPrimary completion
Study to Evaluate Sex Differences in the Acute Effects of PL-3994 in Heart Failure SubjectsNCT04318145PTNPhase 2Terminated2023-12-08Actual

Regulatory dates and decisions

No regulatory events match this view.This does not mean no FDA events have occurred.